This inventor holds 3 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignee: Astrazeneca Ab. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Innovations by Donald Raible in Asthma Treatment
Introduction
Donald Raible is an accomplished inventor based in Berwyn, PA (US). He has made significant contributions to the field of asthma treatment, holding a total of 3 patents. His work focuses on innovative methods to improve the quality of life for asthma patients.
Latest Patents
Raible's latest patents include groundbreaking methods for reducing exacerbation rates of asthma using benralizumab. This patent outlines methods for administering an effective amount of the anti-interleukin-5 receptor (IL-5R) antibody benralizumab to asthma patients. Another notable patent focuses on methods for increasing forced expiratory volume in asthmatics using benralizumab, which involves administering an effective amount of the same antibody to enhance lung function.
Career Highlights
Donald Raible is currently associated with AstraZeneca Ab, a leading pharmaceutical company known for its innovative healthcare solutions. His work at AstraZeneca has allowed him to contribute to the development of effective treatments for asthma, showcasing his commitment to improving patient outcomes.
Collaborations
Raible has collaborated with notable coworkers such as Christine K Ward and Lorin Roskos, further enhancing the impact of his research and innovations in the field of asthma treatment.
Conclusion
Donald Raible's contributions to asthma treatment through his patents and work at AstraZeneca highlight his dedication to advancing medical science. His innovative approaches are paving the way for better management of asthma, ultimately benefiting countless patients.